[1]
“The Application of Cost-Effectiveness and Cost–Benefit Analysis to Pharmaceuticals”, Ricos Bio., vol. 2, no. 2, pp. 59–70, Dec. 2024, doi: 10.33687/ricosbiol.02.02.0032.